TransMedics (TMDX) Share-based Compensation (2018 - 2026)

TransMedics' Share-based Compensation history runs 9 years deep, the most recent figure standing at $10.0 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 11.1% year-over-year to $10.0 million; the TTM figure through Mar 2026 stood at $37.9 million (up 7.2% YoY), while the FY2025 annual figure was $36.9 million, up 10.95% from the prior year.
• Share-based Compensation was $10.0 million for Q1 2026 at TransMedics, up from $9.4 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $10.8 million in Q4 2024 to a low of $2.3 million in Q1 2022.
• Historically, Share-based Compensation has averaged $6.5 million across 5 years, with a median of $6.9 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Share-based Compensation jumped 114.08% in 2023, then decreased 12.74% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $3.0 million in 2022, then surged by 91.37% to $5.7 million in 2023, then surged by 88.1% to $10.8 million in 2024, then fell by 12.74% to $9.4 million in 2025, then rose by 5.93% to $10.0 million in 2026.
• The last three Share-based Compensation figures came in at $10.0 million (Q1 2026), $9.4 million (Q4 2025), and $9.1 million (Q3 2025), per Business Quant data.